vs
布林克公司（BCO）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是布林克公司的1.0倍（$1.4B vs $1.4B），瑞思迈净利率更高（27.6% vs 4.9%，领先22.7%），瑞思迈同比增速更快（11.0% vs 9.1%），过去两年瑞思迈的营收复合增速更高（9.0% vs 5.6%）
布林克公司是总部位于美国弗吉尼亚州里士满的现金处理服务企业，业务范围涵盖武装押运、ATM机加钞与维护，还提供金库外包、货币处理、智能保险柜服务、贵重物品国际运输等现金管理与支付相关解决方案。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
BCO vs RMD — 直观对比
营收规模更大
RMD
是对方的1.0倍
$1.4B
营收增速更快
RMD
高出1.9%
9.1%
净利率更高
RMD
高出22.7%
4.9%
两年增速更快
RMD
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.4B |
| 净利润 | $68.1M | $392.6M |
| 毛利率 | 27.7% | 61.8% |
| 营业利润率 | 13.1% | 34.6% |
| 净利率 | 4.9% | 27.6% |
| 营收同比 | 9.1% | 11.0% |
| 净利润同比 | 76.9% | 13.9% |
| 每股收益（稀释后） | $1.62 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCORMD
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.2B | $1.2B |
净利润BCORMD
| Q4 25 | $68.1M | $392.6M | ||
| Q3 25 | $36.3M | $348.5M | ||
| Q2 25 | $43.7M | $379.7M | ||
| Q1 25 | $51.6M | $365.0M | ||
| Q4 24 | $38.5M | $344.6M | ||
| Q3 24 | $28.9M | $311.4M | ||
| Q2 24 | $46.2M | $292.2M | ||
| Q1 24 | $49.3M | $300.5M |
毛利率BCORMD
| Q4 25 | 27.7% | 61.8% | ||
| Q3 25 | 25.8% | 61.5% | ||
| Q2 25 | 24.9% | 60.8% | ||
| Q1 25 | 24.6% | 59.3% | ||
| Q4 24 | 26.1% | 58.6% | ||
| Q3 24 | 25.0% | 58.6% | ||
| Q2 24 | 25.2% | 58.5% | ||
| Q1 24 | 25.0% | 57.9% |
营业利润率BCORMD
| Q4 25 | 13.1% | 34.6% | ||
| Q3 25 | 11.4% | 33.4% | ||
| Q2 25 | 10.3% | 33.7% | ||
| Q1 25 | 9.6% | 33.0% | ||
| Q4 24 | 8.3% | 32.5% | ||
| Q3 24 | 8.9% | 31.6% | ||
| Q2 24 | 9.3% | 31.2% | ||
| Q1 24 | 9.8% | 31.3% |
净利率BCORMD
| Q4 25 | 4.9% | 27.6% | ||
| Q3 25 | 2.7% | 26.1% | ||
| Q2 25 | 3.4% | 28.2% | ||
| Q1 25 | 4.1% | 28.3% | ||
| Q4 24 | 3.0% | 26.9% | ||
| Q3 24 | 2.3% | 25.4% | ||
| Q2 24 | 3.7% | 23.9% | ||
| Q1 24 | 4.0% | 25.1% |
每股收益（稀释后）BCORMD
| Q4 25 | $1.62 | $2.68 | ||
| Q3 25 | $0.86 | $2.37 | ||
| Q2 25 | $1.03 | $2.58 | ||
| Q1 25 | $1.18 | $2.48 | ||
| Q4 24 | $0.87 | $2.34 | ||
| Q3 24 | $0.65 | $2.11 | ||
| Q2 24 | $1.02 | $1.97 | ||
| Q1 24 | $1.09 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $1.4B |
| 总债务越低越好 | $4.0B | $403.9M |
| 股东权益账面价值 | $277.7M | $6.3B |
| 总资产 | $7.3B | $8.5B |
| 负债/权益比越低杠杆越低 | 14.31× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资BCORMD
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.2B | $932.7M | ||
| Q4 24 | $1.4B | $521.9M | ||
| Q3 24 | $1.2B | $426.4M | ||
| Q2 24 | $1.2B | $238.4M | ||
| Q1 24 | $1.1B | $237.9M |
总债务BCORMD
| Q4 25 | $4.0B | $403.9M | ||
| Q3 25 | $3.8B | $408.7M | ||
| Q2 25 | $3.9B | $658.4M | ||
| Q1 25 | $3.7B | $663.1M | ||
| Q4 24 | $3.7B | $662.9M | ||
| Q3 24 | $3.7B | $667.6M | ||
| Q2 24 | $3.6B | $697.3M | ||
| Q1 24 | $3.4B | $997.0M |
股东权益BCORMD
| Q4 25 | $277.7M | $6.3B | ||
| Q3 25 | $268.5M | $6.1B | ||
| Q2 25 | $254.6M | $6.0B | ||
| Q1 25 | $205.8M | $5.5B | ||
| Q4 24 | $184.9M | $5.3B | ||
| Q3 24 | $277.1M | $5.2B | ||
| Q2 24 | $320.5M | $4.9B | ||
| Q1 24 | $396.4M | $4.6B |
总资产BCORMD
| Q4 25 | $7.3B | $8.5B | ||
| Q3 25 | $7.0B | $8.3B | ||
| Q2 25 | $7.1B | $8.2B | ||
| Q1 25 | $6.6B | $7.6B | ||
| Q4 24 | $6.6B | $7.1B | ||
| Q3 24 | $6.7B | $7.2B | ||
| Q2 24 | $6.6B | $6.9B | ||
| Q1 24 | $6.7B | $6.8B |
负债/权益比BCORMD
| Q4 25 | 14.31× | 0.06× | ||
| Q3 25 | 14.05× | 0.07× | ||
| Q2 25 | 15.48× | 0.11× | ||
| Q1 25 | 18.19× | 0.12× | ||
| Q4 24 | 20.26× | 0.13× | ||
| Q3 24 | 13.39× | 0.13× | ||
| Q2 24 | 11.26× | 0.14× | ||
| Q1 24 | 8.67× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | 3.5% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流BCORMD
| Q4 25 | — | $339.7M | ||
| Q3 25 | $122.1M | $457.3M | ||
| Q2 25 | — | $538.8M | ||
| Q1 25 | $-60.2M | $578.7M | ||
| Q4 24 | $369.8M | $308.6M | ||
| Q3 24 | $58.4M | $325.5M | ||
| Q2 24 | $-66.1M | $440.1M | ||
| Q1 24 | $63.9M | $402.0M |
自由现金流BCORMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | $77.4M | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | $-119.1M | $557.9M | ||
| Q4 24 | $307.2M | $288.0M | ||
| Q3 24 | $7.4M | $307.7M | ||
| Q2 24 | $-122.8M | $415.2M | ||
| Q1 24 | $11.7M | $380.8M |
自由现金流率BCORMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | 5.8% | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | -9.6% | 43.2% | ||
| Q4 24 | 24.3% | 22.5% | ||
| Q3 24 | 0.6% | 25.1% | ||
| Q2 24 | -9.8% | 33.9% | ||
| Q1 24 | 0.9% | 31.8% |
资本支出强度BCORMD
| Q4 25 | 3.5% | 2.0% | ||
| Q3 25 | 3.3% | 3.2% | ||
| Q2 25 | 4.0% | 2.3% | ||
| Q1 25 | 4.7% | 1.6% | ||
| Q4 24 | 5.0% | 1.6% | ||
| Q3 24 | 4.1% | 1.5% | ||
| Q2 24 | 4.5% | 2.0% | ||
| Q1 24 | 4.2% | 1.8% |
现金转化率BCORMD
| Q4 25 | — | 0.87× | ||
| Q3 25 | 3.36× | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | -1.17× | 1.59× | ||
| Q4 24 | 9.61× | 0.90× | ||
| Q3 24 | 2.02× | 1.05× | ||
| Q2 24 | -1.43× | 1.51× | ||
| Q1 24 | 1.30× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCO
暂无分部数据
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
